LAMIVUDINE-ARTESUNATE CO ADMINISTRATION ALTERS PIROXICAM MEDIATED ANALGESIA IN MICE

Authors

  • T.O Olurishe Department of Pharmacology & Therapeutics, PMB 1045, Ahmadu Bello University, Zaria
  • H.O. Kwanashie Department of Pharmacology & Therapeutics, PMB 1045, Ahmadu Bello University, Zaria
  • Anuka J.A. Department of Pharmacology & Therapeutics, PMB 1045, Ahmadu Bello University, Zaria
  • H.M. Muktar Department of Haematology and Blood Transfusion, Ahmadu Bello University Teaching Hospital, PMB 06, Zaria

DOI:

https://doi.org/10.7439/ijbr.v2i3.97

Keywords:

Analgesic, Artesunate

Abstract

Lamivudine-Artesunate co-administration is common in HIV-malaria settings, as well as in prophylaxis from occupational HIV exposure and presumptive malaria treatment. Pain is a symptom often associated with malaria and HIV which is usually treated with piroxicam due to availability, affordability, and low addiction potential. This study evaluated possible analgesic effects of lamivudine and artesunate, and also the effect of lamivudine-artesunate co-administration on piroxicam mediated analgesia in mice using acetic acid-induced writhing method. Animals received 21 day intraperitoneal treatments with vehicle, lamivudine, artesunate or lamivudine/artesunate co-administration. The result showed that artesunate possessed analgesic properties, and also showed that piroxicam mediated analgesia was significantly reduced (p 0.05) in the presence of concomitant lamivudine-artesunate treatment. This data suggests the need for caution and possible alternate analgesics while on lamivudine-artesunate therapy in order to effectively alleviate pain, when this is desired in lamivudine-artesunate co administration.

Downloads

Download data is not yet available.

Downloads

Published

2011-04-01

Issue

Vol. 2 No. 3 (2011): Mar

Section

Original Research Articles

License

Copyright (c) 2011 International Journal of Biomedical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  • An author must submit Copyright form After acceptance of the article.

How to Cite

1.
LAMIVUDINE-ARTESUNATE CO ADMINISTRATION ALTERS PIROXICAM MEDIATED ANALGESIA IN MICE. Int Jour of Biomed Res [Internet]. 2011 Apr. 1 [cited 2026 Mar. 9];2(3):222-7. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/652